-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HMPL-306 in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HMPL-306 in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.HMPL-306 in Acute Myelocytic Leukemia (AML, Acute Myeloblastic...
-
Product Insights
Contrast Agents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Contrast Agents Pipeline Market Report Overview The Contrast Agents pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Positron Emitting Tomography Contrast Agents ·       Magnetic Resonance Imaging (MRI) Contrast Agents ·       Gadolinium-based MRI Contrast Agents...
-
Product Insights
Net Present Value Model: Buntanetap
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Buntanetap Drug Details Buntanetap (ANVS-401 (Posiphen))...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Small Molecule to Agonize CB1 and CB2 for Neurology
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Small Molecule to Agonize CB1 and CB2 for Neurology Drug Details Small molecule is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – EUC-001
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry EUC-001 Drug Details EU-C-001 is under development for the control of intracranial pressure following...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – N-acetyl cysteine amide
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry N-acetyl cysteine amide Drug Details N-acetyl cysteine amide is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – buntanetap tartrate
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry buntanetap tartrate Drug Details Buntanetap (ANVS-401 (Posiphen)) is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ST-266
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ST-266 Drug Details ST-266 is under development for the treatment of ocular hypertension, radiation-induced...
-
Product Insights
Alzheimer Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Alzheimer is a progressive neurologic disorder beginning with mild memory loss. It could possibly lead to a loss of the ability to carry on a conversation and respond to the environment. The Alzheimer pipeline market research report provides comprehensive information about the Alzheimer pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Chronic Traumatic Encephalopathy (CTE) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Chronic Traumatic Encephalopathy (CTE) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Chronic Traumatic Encephalopathy (CTE) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Traumatic Encephalopathy (CTE), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history...